Key learning points:
• Recent research work on the gastrointestinal microbiome of other animal species and its relevance to swine.
• Production challenges, their potentially negative impact on gut health, and possible solutions.
• The impact that proven alternatives to antibiotic growth promoters (AGPs) can have on liveability and production efficiency.
Duration, including questions: 1 hour
Dr. Marcus E. Kehrli, Jr.
Director, National Animal Disease Center, USDA Agricultural Research Service
Dr. Marcus E. Kehrli, Jr. Is currently the Director of the National Animal Disease Center of the USDA’s Agricultural Research Service and has over 32 years of experience in infectious and emerging diseases research.
Dr. Kehrli began his career at the National Animal Disease Center in 1982 after attending Iowa State University, where he received a DVM degree in 1982 and a PhD in 1989 in immunobiology. His first project focused on bovine mastitis, and he later became the Lead Scientist for the Center’s Immunology of Ruminant Perinatal Diseases Project until 1998.
Dr. Kehrli then joined Pfizer Animal Health and from 1998 to 2003 worked as a Principal Research Investigator in Pfizer’s Global Research and Development, and in the Veterinary Medicine Pharmaceutical Discovery Department, where his research focused on the pursuit of novel therapeutic solutions for livestock diseases. In 2003, he returned to the National Animal Disease Center Research as Leader of the Virus and Prion Research Unit. In this role, he has implemented a broad, multidisciplinary program of applied and fundamental research to alleviate the economic impact of bacterial, viral and prion diseases on livestock and wildlife industries. His primary area of research expertise has been immunity to infectious diseases of cattle and swine, and he has received numerous industry awards for his work.